168 related articles for article (PubMed ID: 32628337)
1. Metastatic squamous cell carcinoma transformed from prostatic adenocarcinoma following androgen deprivation therapy: A case report with clinicopathologic and molecular findings.
Lau HD; Clark M
Diagn Cytopathol; 2020 Dec; 48(12):E14-E17. PubMed ID: 32628337
[TBL] [Abstract][Full Text] [Related]
2. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
[TBL] [Abstract][Full Text] [Related]
3. Androgen deprivation modulates gene expression profile along prostate cancer progression.
Volante M; Tota D; Giorcelli J; Bollito E; Napoli F; Vatrano S; Buttigliero C; Molinaro L; Gontero P; Porpiglia F; Tucci M; Papotti M; Berruti A; Rapa I
Hum Pathol; 2016 Oct; 56():81-8. PubMed ID: 27342909
[TBL] [Abstract][Full Text] [Related]
4. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract][Full Text] [Related]
5. Case report: Squamous cell carcinoma of the prostate-a clinicopathological and genomic sequencing-based investigation.
Zhang C; Jia Y; Kong Q
Pathol Oncol Res; 2023; 29():1611343. PubMed ID: 38089646
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS2-ERG fusions unexpectedly identified in men initially diagnosed with nonprostatic malignancies.
Lara PN; Heilmann AM; Elvin JA; Parikh M; de Vere White R; Gandour-Edwards R; Evans CP; Pan CX; Schrock AB; Erlich R; Ross JS; Stephens PJ; McPherson J; Miller VA; Ali SM
JCO Precis Oncol; 2017; 2017():. PubMed ID: 29629426
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical study of androgen receptor in adenocarcinoma of the human prostatic cancer].
Yoshikawa H; Ikeuchi T; Kai Y
Nihon Hinyokika Gakkai Zasshi; 1996 Jul; 87(7):956-63. PubMed ID: 8776961
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma at the prostatectomy site: squamous differentiation of recurrent prostate carcinoma.
Rahmanou F; Koo J; Marinbakh AY; Solliday MP; Grob BM; Chin NW
Urology; 1999 Oct; 54(4):744. PubMed ID: 10754146
[TBL] [Abstract][Full Text] [Related]
9. Transformation of prostatic adenocarcinoma to well-differentiated neuroendocrine tumor after hormonal treatment.
Gilani S; Guo CC; Li-Ning EM; Pettaway C; Troncoso P
Hum Pathol; 2017 Jun; 64():186-190. PubMed ID: 28159676
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
11. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
[TBL] [Abstract][Full Text] [Related]
12. Oligometastatic Squamous Cell Transformation From Metastatic Prostate Adenocarcinoma Treated With Systemic and Focal Therapy: A Case Report.
Autio K; McBride S
J Immunother Precis Oncol; 2022 Aug; 5(3):79-83. PubMed ID: 36034583
[TBL] [Abstract][Full Text] [Related]
13. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy.
Baraban E; Ding CC; White M; Vohra P; Simko J; Boyle K; Guo C; Zhang M; Dobs A; Ketheeswaran S; Liang F; Epstein JI
Am J Surg Pathol; 2022 Dec; 46(12):1650-1658. PubMed ID: 36006769
[TBL] [Abstract][Full Text] [Related]
14. [TMPRSS2-ERG gene fusion in metastatic prostate cancers: a study of fine needle aspiration specimens].
Xiao L; Zhu XZ; Wang Y; Gong Y; Guo CC
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):392-6. PubMed ID: 21914348
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
Bell PD; Huber AR; Agostini-Vulaj D
Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
[TBL] [Abstract][Full Text] [Related]
16. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
[TBL] [Abstract][Full Text] [Related]
17. Primary Prostatic Carcinoma With De Novo Diffuse Neuroendocrine Differentiation.
Galea LA; Mow C; Fine SW; Manohar P
Int J Surg Pathol; 2022 Apr; 30(2):232-236. PubMed ID: 34338584
[TBL] [Abstract][Full Text] [Related]
18. Association of intraductal carcinoma of the prostate detected by initial histological specimen and neuroendocrine prostate cancer: A report of three cases.
Ikeda J; Ohe C; Ohsugi H; Matsuda T; Tsuta K; Kinoshita H
Pathol Int; 2021 Sep; 71(9):621-626. PubMed ID: 34297443
[TBL] [Abstract][Full Text] [Related]
19. Post-therapeutic squamous cell transformation of a metastatic prostate adenocarcinoma with comparison of molecular profiles: a case report and review of the literature.
Li P; Haines GK; Si Q; Baskovich B
Int J Clin Exp Pathol; 2024; 17(3):78-82. PubMed ID: 38577694
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
